IJU this issue.

  title={IJU this issue.},
  author={Mototsugu Oya},
  journal={International journal of urology : official journal of the Japanese Urological Association},
  volume={23 6},
P rostate cancer is associated with molecular, pathological and clinical heterogeneity, and is characterized by androgen-dependent proliferation, which is blocked by androgen deprivation therapy. However, resistance phenotypes can emerge after androgen deprivation therapy, named castration-resistant prostate cancer (CRPC). Mizokami et al. (Kanazawa, Japan… CONTINUE READING